Keywords: servier, agomelatine, approved, europe, european, commission, valdoxan/thymanax

Servier's agomelatine approved in Europe

Article | 02 March 2009

The European Commission has approved Servier's Valdoxan/Thymanax (agomelatine), the first melatonergic antidepressant for the treatment of adult patients with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Servier

Go to company listing